Found 7 matching trials
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia PHASE3 Up to two hundred (200) adult participants with type 1 diabetes (T1D) aged ...
Show More Location
New England Diabetes and Endocrinology Center (NEDEC)
Learn More & Join Trial
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes PHASE2 The purpose of this study was to assess how glucagon administered nasally, ...
Show More Location
Barbara Davis Center for Diabetes
Learn More & Join Trial
Intranasal Glucagon and Energy Balance PHASE2 People who are overweight often find it difficult to lose weight through di...
Show More Location
Toronto General Hospital
Learn More & Join Trial
Assessment of Intranasal Glucagon on Endogenous Glucose Production PHASE1 Peripheral glucagon action increases hepatic glucose production. In rodents...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Ease of Use and Acceptability of Intranasal and Injectable Glucagon Among Providers Administering it to Children or Adolescents With Type 1 Diabetes (BETTER-ING) NA Background : The benefits of good glycemic control are clearly established....
Show More Location
Centre de recherche du CHU de Québec - Université Laval
Learn More & Join Trial
Evaluate the Immunogenicity of a Novel Glucagon Formulation PHASE3 This study provides information on immunogenicity of Nasal Glucagon (AMG504...
Show More Location
Algorithme Pharma Inc.
Learn More & Join Trial
Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes PHASE4 The diagnosis of secondary hypoadrenalism and GH deficiency (GHD) often req...
Show More Location
AOU Città della Salute e della Scienza
Learn More & Join Trial